It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

Weight-loss drugs Ozempic and Wegovy have become popular worldwide. Many people have also reported suffering some serious ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...